BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30843036)

  • 1. Sex differences in rate and rhythm control for atrial fibrillation.
    Weberndörfer V; Beinart R; Ricciardi D; Ector J; Mahfoud M; Szeplaki G; Hemels M;
    Europace; 2019 May; 21(5):690-697. PubMed ID: 30843036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of sex and atrial fibrillation therapies with patient-reported outcomes.
    Gleason KT; Dennison Himmelfarb CR; Ford DE; Lehmann H; Samuel L; Jain S; Naccarelli G; Aggarwal V; Nazarian S
    Heart; 2019 Nov; 105(21):1642-1648. PubMed ID: 31118198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.
    Crijns HJ; Weijs B; Fairley AM; Lewalter T; Maggioni AP; Martín A; Ponikowski P; Rosenqvist M; Sanders P; Scanavacca M; Bash LD; Chazelle F; Bernhardt A; Gitt AK; Lip GY; Le Heuzey JY
    Int J Cardiol; 2014 Apr; 172(3):588-94. PubMed ID: 24556445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC; Hagens VE; Bosker HA; Kingma JH; Kamp O; Kingma T; Said SA; Darmanata JI; Timmermans AJ; Tijssen JG; Crijns HJ;
    N Engl J Med; 2002 Dec; 347(23):1834-40. PubMed ID: 12466507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial fibrillation: current recommendations for diagnosis and treatment].
    Kirchhof P
    Internist (Berl); 2013 May; 54(5):583-95. PubMed ID: 23636440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
    Van Gelder IC; Tuinenburg AE; Schoonderwoerd BS; Tieleman RG; Crijns HJ
    Am J Cardiol; 1999 Nov; 84(9A):147R-151R. PubMed ID: 10568674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute management of atrial fibrillation.
    Khoo CW; Lip GYH
    Chest; 2009 Mar; 135(3):849-859. PubMed ID: 19265095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer developments in the management of atrial fibrillation.
    Nattel S
    Am Heart J; 1995 Nov; 130(5):1094-106. PubMed ID: 7484742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland.
    Kiliszek M; Opolski G; Włodarczyk P; Dąbrowski R; Ponikowski P
    Cardiol J; 2014; 21(5):484-91. PubMed ID: 24526513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current aspects of electrical cardioversion in patients with persistent atrial fibrillation].
    Mickley F; Löscher S; Hartmann A
    Med Klin (Munich); 2004 Jan; 99(1):18-23. PubMed ID: 14716481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
    Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
    Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of recent-onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies.
    Lau DH; Kalman J; Sanders P
    Clin Ther; 2014 Sep; 36(9):1151-9. PubMed ID: 25234548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
    Hagens VE; Ranchor AV; Van Sonderen E; Bosker HA; Kamp O; Tijssen JG; Kingma JH; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2004 Jan; 43(2):241-7. PubMed ID: 14736444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for managing atrial fibrillation.
    Katcher MS; Foote CB; Homoud M; Wang PJ; Estes NA
    Cleve Clin J Med; 1996 Sep; 63(5):282-94. PubMed ID: 8870339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.